TARO-VENLAFAXINE XR 75 MG — DIN 02380080
VENLAFAXINE (VENLAFAXINE HYDROCHLORIDE) : 75 MG · SUN PHARMA CANADA INC · CAPSULE (EXTENDED RELEASE) · wholesale supply in Canada
Health Canada status: MARKETED
What is TARO-VENLAFAXINE XR?
TARO-VENLAFAXINE XR 75 MG contains VENLAFAXINE (VENLAFAXINE HYDROCHLORIDE) : 75 MG. It is listed in the Health Canada Drug Product Database under DIN 02380080, held by SUN PHARMA CANADA INC, supplied as CAPSULE (EXTENDED RELEASE) for ORAL administration. Health Canada currently lists it as marketed, status dated 16-Oct-2020. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
What is TARO-VENLAFAXINE XR used for?
Symptomatic relief of Major Depressive Disorder, Generalized Anxiety Disorder (GAD), Social Anxiety Disorder (Social Phobia), and Panic Disorder.
Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.
How much does Venlafaxine cost around the world?
Venlafaxine is listed on 11 of the national price registers Nexara ingests. Each country publishes on a different basis, so those figures are not comparable with one another — or with a Canadian wholesale price.
What a market publishes matters more than the number it publishes. Australia publishes a ex-manufacturer; Austria publishes a KVP (Kassenverkaufspreis); Bahrain publishes a retail (max). Comparing an ex-factory ceiling against a pharmacy public price tells you nothing about either, and comparing either against a Canadian landed cost tells you less.
| Market | Price basis published there | Brands | Packs listed | Range |
|---|---|---|---|---|
| Austria | KVP (Kassenverkaufspreis) | 23 | 46 | EUR███.██ |
| United States | acquisition | 5 | 41 | USD███.██ |
| Australia | ex-manufacturer | 10 | 35 | AUD███.██ |
| Czechia | max producer price (ex-factory) | 6 | 27 | CZK███.██ |
| South Africa | single exit price | 24 | 24 | ZAR███.██ |
| Greece | producer price (ex-factory) | 21 | 21 | EUR███.██ |
| Luxembourg | reimbursement | 17 | 17 | EUR███.██ |
| Hungary | producer price (ex-factory) | 6 | 8 | HUF███.██ |
| United Kingdom | hospital | 7 | 7 | GBP███.██ |
| Morocco | PPV (public price) | 3 | 7 | MAD███.██ |
| Bahrain | retail (max) | 2 | 5 | BHD███.██ |
238 pack listings across 124 brand entries and 10 price bases, refreshed 08 Sep 2026. Ranges span every Venlafaxine pack in that market, so a high figure is usually a larger pack rather than the same product.
Canada publishes no comparable public list price. For a delivered Canadian price on a licensed account, verify your licence — it takes about a minute.
Is there a generic Venlafaxine in Canada, and who makes it?
Every market authorization holder with a Canadian DIN for this molecule, and how many of their listings Health Canada currently shows as marketed.
24 holders have a Canadian DIN containing Venlafaxine, across 90 DINs, of which 36 are currently marketed. Marketed count is the number that matters: an approval that is not marketed cannot be bought.
| Market authorization holder | DINs | Marketed | Brand names | Position |
|---|---|---|---|---|
| TEVA CANADA LIMITED | 12 | 3 | ACT VENLAFAXINE XR, NTP-VENLAFAXINE XR, TEVA-VENLAFAXINE XR, VENLAFAXINE XR | Sourceable in Canada |
| PHARMASCIENCE INC | 9 | 3 | PMS-VENLAFAXINE XR, PMSC-VENLAFAXINE XR, VENLAFAXINE XR | Sourceable in Canada |
| LABORATOIRE RIVA INC. | 6 | 3 | RIVA-VENLAFAXINE XR, VENLAFAXINE XR | Sourceable in Canada |
| AURO PHARMA INC | 3 | 3 | AURO-VENLAFAXINE XR | Sourceable in Canada |
| BGP PHARMA ULC | 3 | 3 | EFFEXOR XR | Sourceable in Canada |
| JAMP PHARMA CORPORATION | 3 | 3 | VENLAFAXINE XR | Sourceable in Canada |
| MANTRA PHARMA INC | 3 | 3 | M-VENLAFAXINE XR | Sourceable in Canada |
| PRO DOC LIMITEE | 3 | 3 | VENLAFAXINE XR | Sourceable in Canada |
| SANDOZ CANADA INCORPORATED | 3 | 3 | SANDOZ VENLAFAXINE XR | Sourceable in Canada |
| SANIS HEALTH INC | 3 | 3 | VENLAFAXINE XR | Sourceable in Canada |
| SIVEM PHARMACEUTICALS ULC | 3 | 3 | VENLAFAXINE XR | Sourceable in Canada |
| SUN PHARMA CANADA INC | 3 | 3 | TARO-VENLAFAXINE XR | Sourceable in Canada |
Health Canada’s Drug Product Database does not flag which listing is the originator and which are subsequent-entry products, so Nexara does not label them here. Interchangeability is determined provincially, not federally — confirm for your province before a formulary switch. Nexara can confirm which of these is actually obtainable, and on what lead time, per order.
How is it supplied and stored?
Pack configuration, storage class and the handling constraints that drive cold-chain planning. One DIN can cover more than one pack size, and the pack — not the DIN — is what gets priced, shipped and invoiced.
| Strength on the label | 75 MG |
|---|---|
| Dosage form | CAPSULE (EXTENDED RELEASE) |
| Route | ORAL |
| Pack configuration (monograph) | Not fully specified in text provided (Table 1 cut off), but available in 37.5 mg, 75 mg, and 150 mg strengths. |
| Storage | Not specified in the provided text (refer to section 11). |
Before an order line is unambiguous Nexara needs the strength, the pack size and the presentation, because this listing covers more than one of them.
Substance and classification
| Active substance | Venlafaxine |
|---|---|
| ATC code | N06AX16 |
| AHFS class | 28:16.04.16 |
| Biosimilar biologic | No |
Health Canada record and identifiers
The regulatory facts straight from the Drug Product Database, plus every identifier form Nexara accepts on a purchase order. A DIN written without its leading zeros is the commonest reason an order line fails to match.
| DIN (8-digit, as used in ordering) | 02380080 |
|---|---|
| DIN (unpadded, as printed on some documents) | 2380080 |
| Brand name | TARO-VENLAFAXINE XR |
| Generic / active ingredient | VENLAFAXINE (VENLAFAXINE HYDROCHLORIDE) : 75 MG |
| Market authorization holder | SUN PHARMA CANADA INC |
| Health Canada schedule | Prescription |
| ATC code | N06AX16 |
| ATC anatomical main group | N — Nervous system |
| ATC therapeutic subgroup | N06AX |
| Current status | MARKETED |
| Status date | 16-Oct-2020 |
| Original market date | 2012-02-16 00:00:00 |
| Status source | Live Health Canada DPD sync |
Verify on the primary sources
How is it administered?
Administer once daily with food. MDD/GAD/Social Anxiety: 75 mg/day (start 37.5 mg for 4-7 days). Panic Disorder: 37.5 mg for 7 days, then 75 mg. Max 225 mg/day. Taper gradually to discontinue.
Included because it drives pack selection and wastage. Consult the monograph.
Contraindications
Hypersensitivity to venlafaxine or any ingredient; concurrent use of MAOIs (or within 14 days of stopping/starting MAOIs).
Warnings and precautions
Serious Warning: Increased risk of self-harm, suicidal thinking and behavior. Monitor for clinical worsening. Risk of Serotonin Syndrome and Neuroleptic Malignant Syndrome.
Is Venlafaxine in shortage in Canada?
A Canadian shortage report is on file for a product containing this molecule: Resolved — reported by JAMP PHARMA CORPORATION, last seen 04 Sep 2026. A shortage on one presentation does not always affect every DIN of the molecule — the alternatives below list what else is marketed in Canada. Nexara can confirm current availability and identify substitutions or import options where permitted.
What can be used instead?
Alternatives on every axis a buyer actually considers — the same molecule in another presentation, the same class, an adjacent class, or a fixed-dose combination. Every row is led by the marketed DIN count, because that is what can be bought this week.
1 · Same molecule, other Canadian presentations
36 of 90 Canadian DINs for this molecule are currently marketed. Marketed products are listed first.
| Product | Strength | Form | Holder | Health Canada status | DIN |
|---|---|---|---|---|---|
| ACT VENLAFAXINE XR | 75 MG | CAPSULE (EXTENDED RELEASE) | TEVA CANADA LIMITED | MARKETED | 02304325 |
| ACT VENLAFAXINE XR | 150 MG | CAPSULE (EXTENDED RELEASE) | TEVA CANADA LIMITED | MARKETED | 02304333 |
| ACT VENLAFAXINE XR | 37.5 MG | CAPSULE (EXTENDED RELEASE) | TEVA CANADA LIMITED | MARKETED | 02304317 |
| AURO-VENLAFAXINE XR | 75 MG | CAPSULE (EXTENDED RELEASE) | AURO PHARMA INC | MARKETED | 02452847 |
| AURO-VENLAFAXINE XR | 37.5 MG | CAPSULE (EXTENDED RELEASE) | AURO PHARMA INC | MARKETED | 02452839 |
| AURO-VENLAFAXINE XR | 150 MG | CAPSULE (EXTENDED RELEASE) | AURO PHARMA INC | MARKETED | 02452855 |
| EFFEXOR XR | 150 MG | CAPSULE (EXTENDED RELEASE) | BGP PHARMA ULC | MARKETED | 02237282 |
| EFFEXOR XR | 75 MG | CAPSULE (EXTENDED RELEASE) | BGP PHARMA ULC | MARKETED | 02237280 |
| EFFEXOR XR | 37.5 MG | CAPSULE (EXTENDED RELEASE) | BGP PHARMA ULC | MARKETED | 02237279 |
| M-VENLAFAXINE XR | 37.5 MG | CAPSULE (EXTENDED RELEASE) | MANTRA PHARMA INC | MARKETED | 02471280 |
2 · Same class — other molecules in ATC N06AX
| Molecule | Canadian brands | DINs | Marketed | Sourceable |
|---|---|---|---|---|
| Venlafaxine | ACT VENLAFAXINE XR · APO-VENLAFAXINE XR · AURO-VENLAFAXINE XR · DOM-VENLAFAXINE XR · EFFEXOR TABLETS, 37.5MG · EFFEXOR TABLETS, 50MG · EFFEXOR TABLETS, 75MG · EFFEXOR XR · GD-VENLAFAXINE XR · M-VENLAFAXINE XR · MAR-VENLAFAXINE XR · MINT-VENLAFAXINE XR · MYLAN-VENLAFAXINE XR · NTP-VENLAFAXINE XR · PHL-VENLAFAXINE XR · PMS-VENLAFAXINE XR · PMSC-VENLAFAXINE XR · RIVA-VENLAFAXINE XR · SANDOZ VENLAFAXINE XR · TARO-VENLAFAXINE XR · TEVA-VENLAFAXINE XR · VENLAFAXINE HYDROCHLORIDE EXTENDED-RELEASE CAPSULES · VENLAFAXINE XR | 90 | 36 | Yes |
| Duloxetine | ACCEL-DULOXETINE · AG-DULOXETINE · APO-DULOXETINE · AURO-DULOXETINE · BIO-DULOXETINE · CYMBALTA · DOM-DULOXETINE · DULOXETINE · DULOXETINE DR · IPG-DULOXETINE · JAMP DULOXETINE · JAMP DULOXETINE CAPSULES · JAMP-DULOXETINE · M-DULOXETINE · MAR-DULOXETINE · MINT-DULOXETINE · MYLAN-DULOXETINE · NRA-DULOXETINE · PMS-DULOXETINE · PRIVA-DULOXETINE · RAN-DULOXETINE · RIVA-DULOXETINE · SANDOZ DULOXETINE · STR-DULOXETINE · TARO-DULOXETINE · TEVA-DULOXETINE · TEVA-DULOXETINE DR · TORRENT-DULOXETINE | 66 | 36 | Yes |
| Mirtazapine | APO-MIRTAZAPINE · AURO-MIRTAZAPINE · AURO-MIRTAZAPINE OD · AVA-MIRTAZAPINE · CO MIRTAZAPINE · DOM-MIRTAZAPINE · GD-MIRTAZAPINE OD · JAMP-MIRTAZAPINE · MIRTAZAPINE · MIRTAZAPINE - 15 · MIRTAZAPINE - 30 · MIRTAZAPINE - 45 · MYLAN-MIRTAZAPINE · NRA-MIRTAZAPINE · NTP-MIRTAZAPINE · NTP-MIRTAZAPINE OD TABLETS · NU-MIRTAZAPINE · PMS-MIRTAZAPINE · PRO-MIRTAZAPINE · RATIO-MIRTAZAPINE · REMERON · REMERON RD · RIVA-MIRTAZAPINE · SANDOZ MIRTAZAPINE · SANDOZ MIRTAZAPINE FC · TEVA-MIRTAZAPINE · TEVA-MIRTAZAPINE OD · ZYM-MIRTAZAPINE | 64 | 31 | Yes |
| Trazodone | AG-TRAZODONE · APO-TRAZODONE D TABLETS 150MG · APO-TRAZODONE TABLETS 100MG · APO-TRAZODONE TABLETS 50MG · DESYREL DIVIDOSE TAB 300MG · DESYREL DIVIDOSE TABLET 150 MG · DESYREL TAB 100MG · DESYREL TAB 50MG · DOM-TRAZODONE TABLETS - 50MG · DOM-TRAZODONE TABLETS-100MG · JAMP TRAZODONE · MYLAN-TRAZODONE · NTP-TRAZODONE · NU-TRAZODONE - TAB 100MG · NU-TRAZODONE - TAB 50MG · NU-TRAZODONE-D - TAB 150MG · OLEPTRO · PENTA-TRAZODONE TABLETS · PHL-TRAZODONE · PMS TRAZODONE HCL TAB 100MG · PMS TRAZODONE HCL TAB 50MG · PMS-TRAZODONE · RATIO-TRAZODONE · RATIO-TRAZODONE TAB 150MG · RATIO-TRAZODONE TABLETS 100MG · RATIO-TRAZODONE TABLETS 50MG · SCHEINPHARM TRAZODONE · TEVA-TRAZODONE · TRAZODONE · TRAZODONE-100 · TRAZODONE-150 D · TRAZODONE-50 · TRAZOREL · ZYM-TRAZODONE | 57 | 21 | Yes |
| Desvenlafaxine | AG-DESVENLAFAXINE · APO-DESVENLAFAXINE · APO-DESVENLAFAXINE EXTENDED-RELEASE TABLETS · DESVENLAFAXINE · GD-DESVENLAFAXINE · INTELLI-DESVENLAFAXINE · JAMP DESVENLAFAXINE · PRISTIQ · PRO-DESVENLAFAXINE · SANDOZ DESVENLAFAXINE · TARO-DESVENLAFAXINE · TEVA-DESVENLAFAXINE | 28 | 20 | Yes |
| Tryptophan | APO-TRYPTOPHAN · DOM-TRYPTOPHAN · PHL-TRYPTOPHAN · PMS-TRYPTOPHAN · TEVA-TRYPTOPHAN · TRYPTAN | 20 | 11 | Yes |
| Bupropion | AVA-BUPROPION SR · BUPROPION HCL SR · BUPROPION HCL XL · BUPROPION SR · DOM-BUPROPION SR · MYLAN-BUPROPION XL · NOVO-BUPROPION SR · NOVO-BUPROPION SR TABLETS · ODAN BUPROPION SR · PHL-BUPROPION SR · PMS-BUPROPION SR · RATIO-BUPROPION SR · TARO-BUPROPION XL · TEVA-BUPROPION XL · WELLBUTRIN SR · WELLBUTRIN XL · ZYBAN | 32 | 9 | Yes |
| Vortioxetine | APO-VORTIOXETINE · TRINTELLIX | 8 | 6 | Yes |
| Vilazodone | APO-VILAZODONE · VIIBRYD | 8 | 6 | Yes |
| Levomilnacipran | FETZIMA | 4 | 4 | Yes |
A molecule with zero marketed DINs cannot be sourced domestically, however many approvals it holds — if one of these sits on a formulary or in an older protocol, that is the line to check.
3 · Adjacent classes in ATC N06A
| ATC subgroup | Molecules | DINs | Marketed |
|---|---|---|---|
| N06AB | Citalopram · Escitalopram · Fluoxetine · Fluvoxamine · Paroxetine · Sertraline | 589 | 248 |
| N06AA | Amitriptyline · Amoxapine · Clomipramine · Desipramine · Doxepin · Imipramine · Maprotiline · Nortriptyline · Protriptyline · Trimipramine | 325 | 62 |
| N06AG | Moclobemide | 21 | 4 |
| N06AF | Tranylcypromine | 2 | 2 |
Not clinical advice. These tables describe what can be supplied in Canada, not what should be prescribed. Substitution within or across classes is a prescriber and pharmacist decision, and interchangeability is determined provincially.
What else is TARO-VENLAFAXINE XR called?
The same molecule, Venlafaxine, is registered under other names elsewhere. Buyers and prescribers searching from outside Canada — or working from a foreign prescription or tender document — often know it by one of these:
| Name | Script | Registered in |
|---|---|---|
| VENLAFAXIN VIATRIS | Latin | Czechia |
| Efexor-XR | Latin | Australia |
| VELAXIN | Latin | Czechia |
| VENLAFAXINE XR-WGR | Latin | Australia |
| APO-Venlafaxine XR | Latin | Australia |
| ARGOFAN | Latin | Czechia |
| BTC Venlafaxine XR | Latin | Australia |
| EFECTIN ER | Latin | Czechia |
| Enlafax-XR | Latin | Australia |
| Sandoz Venlafaxine XR | Latin | Australia |
| VENLAFAXIN MYLAN | Latin | Czechia |
| Venlafaxine generichealth XR | Latin | Australia |
| EFFEXOR | Latin | Morocco |
| VEXAL XR | Latin | Bahrain |
| EFEXOR XR | Latin | Bahrain |
Names are taken from national medicine registers and published price lists. A product registered abroad is not authorized for sale in Canada unless it holds its own DIN; import is possible only through the routes Health Canada permits.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address. Patients and unlicensed buyers are routed to a partner pharmacy.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Why is there no price on this page?
Nexara quotes a delivered Canadian price per order, against a verified licence. Foreign list prices are published on incompatible bases and are not a guide to what any buyer can obtain here, so this page shows which markets list the molecule and on what basis, and nothing more.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.